PI
SGEN

PineBridge Investments’s Seagen Inc. Common Stock SGEN Stock Holding History

PineBridge Investments’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,955
Closed -$414K – 715
2023
Q3 		$414K Buy
+1,955
New +$391K ﹤0.01% 549
2021
Q3 		– Sell
-12,135
Closed -$1.92M – 683
2021
Q2 		$1.92M Sell
12,135
-16,160
-57% -$2.4M 0.02% 434
2021
Q1 		$3.93M Buy
28,295
+10,667
+61% +$1.72M 0.05% 353
2020
Q4 		$3.09M Buy
+17,628
New +$3.29M 0.05% 326

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

PineBridge Investments's SGEN Position: Q4 2023 in Review

PineBridge Investments sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,955 shares — an estimated $414K sold.

PineBridge Investments first reported a position in SGEN in Q4 2020 and held it in 4 quarters. The position peaked at $3.93M in Q1 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • PineBridge Investments reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • PineBridge Investments sold 1,955 Seagen Inc. Common Stock shares in Q4 2023, an estimated $414K.
  • PineBridge Investments first reported a position in Seagen Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • PineBridge Investments's Seagen Inc. Common Stock position peaked at $3.93M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on PineBridge Investments's 13F filing for Q4 2023, filed 13 Feb 2024.